Epstein-Barr virus latent membrane protein-1 oncogene deletions in Hodgkin's disease and gastric carcinoma in Japan and Nepal.
日本和尼泊尔霍奇金病和胃癌中 Epstein-Barr 病毒潜伏膜蛋白 1 癌基因缺失。
基本信息
- 批准号:09670177
- 负责人:
- 金额:$ 1.86万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The presence of 30-bp deletions within the carboxy terminal end of the LMP-1 oncogene of EBV has been reported in EBV-aasociated neolasms. We analysed the 30-bp deletion of the LMP-1 gene in Hodgkin's disease and gastric carcinoma in Japan and Nepal. 35% of Hodgkin's cells in Japan showed positive reaction for LMP-1. Direct sequence analysis of the PCR products of carboxy terminal end of the LMP-1 oncogene revealed identical 30-bp deletion in 5 of 6 samples of EBV-associated Hodgkin's disease. In EBV-associated gastric carcinoma in Japan, this deletion was found in 2 of 3 samples.On the other hand, 100% of Hodgkin's cells showed positive reaction for LMP-1 in Nepal. Identical 30-bp deletion was observed in 4 of 8 samples.Furthermore we examined the proliferating activity and P53 expression of Hodgkin's cells with and without 30-bp deletion. However proliferating activity and P53 expression was almost similar between these two groups.Our results suggest that the 30-bp deletion mutant is widely spread in Japan and Nepal and is not implicated in EBV-associated neolasms.
在EB病毒相关的新瘤中,已经报道了EB病毒LMP-1癌基因羧基末端内30-bp缺失的存在。我们分析了日本和尼泊尔霍奇金病和胃癌中LMP-1基因的30 bp缺失。日本35%的霍奇金淋巴瘤细胞显示LMP-1阳性反应。6例EBV相关性霍奇金病中5例LMP-1癌基因羧基端缺失。在日本的EBV相关胃癌中,3例标本中有2例发现这种缺失,而在尼泊尔的霍奇金淋巴瘤细胞中,100%的LMP-1呈阳性反应。在8例标本中有4例发现30-bp缺失,并进一步检测了30-bp缺失前后霍奇金淋巴瘤细胞的增殖活性和P53蛋白表达。我们的研究结果表明30-bp缺失突变体在日本和尼泊尔广泛分布,并且与EBV相关的neolasms无关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ishii G: "Interbukin-II gene expression in human lpmphoid mabgnanuy" Hematology. 3. 143-151 (1998)
Ishii G:“人淋巴组织中的 Interbukin-II 基因表达”血液学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Isobe, K: "Clinicopathological evaluation of the Revired European-American classification of lymphid Neoplams(REAL) in Japan" Lenkemia and lymphoma. in press
Isobe, K:“日本修订的欧美淋巴肿瘤分类 (REAL) 的临床病理学评估” 白血病和淋巴瘤。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ISHII Genichiro其他文献
ISHII Genichiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ISHII Genichiro', 18)}}的其他基金
Development of target therapy for stromal cells
基质细胞靶向治疗的发展
- 批准号:
24659185 - 财政年份:2012
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Mechanism of tumor promoting effect by mesenchymal progenitor cell
间充质祖细胞促瘤作用机制
- 批准号:
20590417 - 财政年份:2008
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
In vivo and in vitro characterization of bone-marrow derived fibroblast recruited into cancer induced stroma.
招募到癌症诱导基质中的骨髓来源成纤维细胞的体内和体外表征。
- 批准号:
17590366 - 财政年份:2005
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of bone-marrow derived fibroblast recruited into cancer induced stroma.
招募到癌症诱导基质中的骨髓来源成纤维细胞的表征。
- 批准号:
15590359 - 财政年份:2003
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Antibodies against Epstein-Barr Virus Latent Membrane Protein 1 and aggregation of alpha-synuclein
抗 Epstein-Barr 病毒潜膜蛋白 1 的抗体和 α-突触核蛋白的聚集
- 批准号:
253405 - 财政年份:2012
- 资助金额:
$ 1.86万 - 项目类别:
Studentship Programs
Functional and expressional analysis of EBV latent membrane protein-1 (LMP-1) in nasal NK/T-cell lymphoma
鼻 NK/T 细胞淋巴瘤中 EBV 潜伏膜蛋白 1 (LMP-1) 的功能和表达分析
- 批准号:
19791180 - 财政年份:2007
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Research of T cell immunity to Epstein-Barr virus latent membrane protein 1.
T细胞对Epstein-Barr病毒潜伏膜蛋白的免疫研究1.
- 批准号:
15590429 - 财政年份:2003
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEIN 1
EBV 潜膜蛋白 1 的转化
- 批准号:
6642888 - 财政年份:2002
- 资助金额:
$ 1.86万 - 项目类别:
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEIN 1
EBV 潜膜蛋白 1 的转化
- 批准号:
6493590 - 财政年份:2001
- 资助金额:
$ 1.86万 - 项目类别:
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEIN 1
EBV 潜膜蛋白 1 的转化
- 批准号:
6344694 - 财政年份:2000
- 资助金额:
$ 1.86万 - 项目类别:
TRANSFORMATION BY EBV LATENT MEMBRANE PROTEIN 1
EBV 潜膜蛋白 1 的转化
- 批准号:
6203028 - 财政年份:1999
- 资助金额:
$ 1.86万 - 项目类别:
LATENT MEMBRANE PROTEIN-1 OF EBV IN THE RECOGNITION OF INFECTED B LYMPHOCYTES
EBV 潜膜蛋白-1 在识别感染 B 淋巴细胞中的作用
- 批准号:
3839151 - 财政年份:
- 资助金额:
$ 1.86万 - 项目类别: